US Stock MarketDetailed Quotes

SONN Sonnet BioTherapeutic

Watchlist
  • 1.7700
  • +0.0700+4.12%
Close Apr 18 16:00 ET
5.43MMarket Cap-2132P/E (TTM)

Sonnet BioTherapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
Total revenue
-50.00%18.63K
-57.76%147.81K
-40.63%37.26K
-40.63%36.85K
-61.77%36.45K
-71.30%37.26K
-27.64%349.94K
-87.02%62.75K
62.07K
95.32K
Operating revenue
-50.00%18.63K
-57.76%147.81K
-40.63%37.26K
-40.63%36.85K
-61.77%36.45K
-71.30%37.26K
-27.64%349.94K
-87.02%62.75K
--62.07K
--95.32K
Cost of revenue
Gross profit
Operating expense
-77.03%1.3M
-36.91%18.94M
-51.11%3.64M
-50.16%3.95M
-31.36%5.7M
-10.96%5.65M
17.40%30.02M
0.12%7.44M
27.08%7.93M
37.58%8.31M
Selling and administrative expenses
-65.67%653.46K
-16.90%7.13M
-22.50%1.79M
-32.35%1.54M
-0.83%1.88M
-8.43%1.9M
-4.04%8.58M
-3.30%2.32M
-3.06%2.28M
-13.49%1.9M
-General and administrative expense
-65.67%653.46K
-16.90%7.13M
-22.50%1.79M
-32.35%1.54M
-0.83%1.88M
-8.43%1.9M
-4.04%8.58M
-3.30%2.32M
-3.06%2.28M
-13.49%1.9M
Research and development costs
-82.81%644.04K
-44.90%11.81M
-64.04%1.84M
-57.35%2.41M
-40.41%3.82M
-12.19%3.75M
28.91%21.44M
1.75%5.12M
45.32%5.65M
66.79%6.41M
Operating profit
77.21%-1.28M
36.66%-18.79M
51.20%-3.6M
50.23%-3.92M
31.00%-5.66M
9.70%-5.61M
-18.26%-29.67M
-6.19%-7.38M
-26.09%-7.87M
-36.00%-8.21M
Net non-operating interest income expense
Other net income (expense)
57.09%110.36K
23.64%-40.08K
-31.21%-76.59K
-220.93%-31.43K
-234.13%-2.3K
402.84%70.25K
-150.73%-52.48K
-1,021.75%-58.38K
-107.90%-9.79K
182.71%1.72K
Gain on sale of security
57.09%110.36K
23.64%-40.08K
-31.21%-76.59K
-220.93%-31.43K
-234.13%-2.3K
402.84%70.25K
-138.11%-52.48K
-1,021.75%-58.38K
-547.32%-9.79K
182.71%1.72K
Income before tax
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
-28.80%-7.88M
-35.92%-8.21M
Income tax
Net income
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
-28.80%-7.88M
-35.92%-8.21M
Net income continuous Operations
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
-28.80%-7.88M
-35.92%-8.21M
Minority interest income
Net income attributable to the parent company
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
-28.80%-7.88M
-35.92%-8.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
78.92%-1.17M
36.64%-18.83M
50.55%-3.68M
49.90%-3.95M
30.96%-5.67M
10.62%-5.54M
-18.96%-29.72M
-6.95%-7.44M
-28.80%-7.88M
-35.92%-8.21M
Basic earnings per share
98.24%-0.31
87.95%-18.14
94.29%-2.1005
92.86%-2.86
82.20%-7.48
44.38%-17.62
51.99%-150.52
-3.49%-36.78
51.85%-40.04
57.37%-42.02
Diluted earnings per share
98.24%-0.31
87.95%-18.14
94.29%-2.1005
92.86%-2.86
82.20%-7.48
44.38%-17.62
51.99%-150.52
-3.49%-36.78
51.85%-40.04
57.37%-42.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022
Total revenue -50.00%18.63K-57.76%147.81K-40.63%37.26K-40.63%36.85K-61.77%36.45K-71.30%37.26K-27.64%349.94K-87.02%62.75K62.07K95.32K
Operating revenue -50.00%18.63K-57.76%147.81K-40.63%37.26K-40.63%36.85K-61.77%36.45K-71.30%37.26K-27.64%349.94K-87.02%62.75K--62.07K--95.32K
Cost of revenue
Gross profit
Operating expense -77.03%1.3M-36.91%18.94M-51.11%3.64M-50.16%3.95M-31.36%5.7M-10.96%5.65M17.40%30.02M0.12%7.44M27.08%7.93M37.58%8.31M
Selling and administrative expenses -65.67%653.46K-16.90%7.13M-22.50%1.79M-32.35%1.54M-0.83%1.88M-8.43%1.9M-4.04%8.58M-3.30%2.32M-3.06%2.28M-13.49%1.9M
-General and administrative expense -65.67%653.46K-16.90%7.13M-22.50%1.79M-32.35%1.54M-0.83%1.88M-8.43%1.9M-4.04%8.58M-3.30%2.32M-3.06%2.28M-13.49%1.9M
Research and development costs -82.81%644.04K-44.90%11.81M-64.04%1.84M-57.35%2.41M-40.41%3.82M-12.19%3.75M28.91%21.44M1.75%5.12M45.32%5.65M66.79%6.41M
Operating profit 77.21%-1.28M36.66%-18.79M51.20%-3.6M50.23%-3.92M31.00%-5.66M9.70%-5.61M-18.26%-29.67M-6.19%-7.38M-26.09%-7.87M-36.00%-8.21M
Net non-operating interest income expense
Other net income (expense) 57.09%110.36K23.64%-40.08K-31.21%-76.59K-220.93%-31.43K-234.13%-2.3K402.84%70.25K-150.73%-52.48K-1,021.75%-58.38K-107.90%-9.79K182.71%1.72K
Gain on sale of security 57.09%110.36K23.64%-40.08K-31.21%-76.59K-220.93%-31.43K-234.13%-2.3K402.84%70.25K-138.11%-52.48K-1,021.75%-58.38K-547.32%-9.79K182.71%1.72K
Income before tax 78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M-28.80%-7.88M-35.92%-8.21M
Income tax
Net income 78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M-28.80%-7.88M-35.92%-8.21M
Net income continuous Operations 78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M-28.80%-7.88M-35.92%-8.21M
Minority interest income
Net income attributable to the parent company 78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M-28.80%-7.88M-35.92%-8.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 78.92%-1.17M36.64%-18.83M50.55%-3.68M49.90%-3.95M30.96%-5.67M10.62%-5.54M-18.96%-29.72M-6.95%-7.44M-28.80%-7.88M-35.92%-8.21M
Basic earnings per share 98.24%-0.3187.95%-18.1494.29%-2.100592.86%-2.8682.20%-7.4844.38%-17.6251.99%-150.52-3.49%-36.7851.85%-40.0457.37%-42.02
Diluted earnings per share 98.24%-0.3187.95%-18.1494.29%-2.100592.86%-2.8682.20%-7.4844.38%-17.6251.99%-150.52-3.49%-36.7851.85%-40.0457.37%-42.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg